Jiao Shen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Oxidative Stress

Tandem Mass Spectrometry

Metal Organic Framework

Top Venues

Nature communications

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhuangzhi Zou, Jiao Shen, Diyuan Xue, Hongjia Li, Longxin Xu, Weian Cao, Wenyan Wang, Yang-Xin Fu, Hua Peng
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8 + T cells for systemic antitumor responses. Nature communications 15 (1) (2024)
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, Hongjia Li, Longxin Xu, Weian Cao, Wenyan Wang, Yang-Xin Fu, Hua Peng
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8 + T cells for systemic antitumor responses. Nature communications 15 (1) (2024)
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, Hongjia Li, Longxin Xu, Weian Cao, Wenyan Wang, Yang-Xin Fu, Hua Peng
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8 + T cells for systemic antitumor responses. Nature communications 15 (1) (2024)
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, Hongjia Li, Longxin Xu, Weian Cao, Wenyan Wang, Yang-Xin Fu, Hua Peng
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8 + T cells for systemic antitumor responses. Nature communications 15 (1) (2024)
Jiao Shen, Zhuangzhi Zou, Jingya Guo, Yueqi Cai, Diyuan Xue, Yong Liang, Wenyan Wang, Hua Peng, Yang-Xin Fu
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery. The Journal of experimental medicine 219 (12) (2022)